This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Grifols Therapeutics Inc., Microsoft Technology Licensing, LLC. Active years: 2012-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2012-2026
Title: Vikram Arora: Innovator in Ophthalmic Therapeutics
Introduction
Vikram Arora is a notable inventor based in Morrisville, NC (US). He has made significant contributions to the field of ophthalmic therapeutics, particularly through his innovative work on recombinant plasmin.
Latest Patents
Vikram holds a patent for "Recombinant plasmin for ophthalmic indications." This patent includes methods of using polynucleotides and polypeptides related to a recombinantly-modified plasmin(ogen) molecule. The invention focuses on applications related to vitrectomy or vitreolysis. The plasmin(ogen) molecule features a single kringel domain N-terminal to the activation site found in the native human plasminogen molecule. It exhibits lysine-binding and significant enzymatic characteristics associated with the native enzyme. Vikram has 1 patent to his name.
Career Highlights
Vikram Arora is currently employed at Grifols Therapeutics Inc., where he continues to advance his research and development efforts in the field of ophthalmology. His work is instrumental in creating innovative solutions for eye-related medical conditions.
Collaborations
Vikram collaborates with talented professionals in his field, including Philip Scuderi, Jr. and Jennifer Audrey Hunt. Their combined expertise contributes to the success of their projects and innovations.
Conclusion
Vikram Arora is a pioneering inventor whose work in recombinant plasmin has the potential to transform ophthalmic treatments. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile